You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

donor hematopoietic engraftment

Showing 1 - 25 of 5,486
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immune Tolerance Trial in Palo Alto (Combined Deceased Donor Kidney and Hematopoietic Cell Transplants)

Enrolling by invitation
  • Immune Tolerance
  • Combined Deceased Donor Kidney and Hematopoietic Cell Transplants
  • Palo Alto, California
    Stanford University
May 6, 2022

Fanconi Anemia Trial in Stanford (drug, device, biological)

Recruiting
  • Fanconi Anemia
  • Stanford, California
    Stanford University
Feb 2, 2022

Hematological Disease, Allogeneic Hematopoietic Stem Cell Transplantation Trial in Tianjin (Hetrombopag, )

Recruiting
  • Hematological Disease
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital, Chinese Acade
Feb 6, 2023

Hematopoietic Stem Cell Transplantation, Hematologic Malignancy Trial (CliniMACS®)

Not yet recruiting
  • Hematopoietic Stem Cell Transplantation
  • Hematologic Malignancy
  • CliniMACS®
  • (no location specified)
Oct 17, 2023

Engraftment Syndrome Trial (Budesonide)

Not yet recruiting
  • Engraftment Syndrome
  • (no location specified)
Aug 19, 2022

Acute Myeloid Leukemia Trial in Saint Louis (Graft cell infusion, Tacrolimus, Mycophenolate mofetil)

Recruiting
  • Acute Myeloid Leukemia
  • Graft cell infusion
  • +6 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 29, 2023

Leukemia, Lymphoma Trial in Memphis (radiation, drug, biological, device)

Completed
Has Results
  • Leukemia
  • Lymphoma
  • Total Lymphoid Irradiation
  • +10 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 28, 2022

Severe Aplastic Anemia, MDS (Myelodysplastic Syndrome) Trial in Baltimore, Bethesda, Minneapolis (Miltenyi CD34 Reagent System,

Recruiting
  • Severe Aplastic Anemia
  • MDS (Myelodysplastic Syndrome)
  • Miltenyi CD34 Reagent System
  • Donor derived G-CSF mobilized PBC
  • Baltimore, Maryland
  • +2 more
Jan 25, 2023

Hematologic Tumors Trial run by the NCI (donor lymphocyte infusion, Cyclophosphamide, Busulfan)

Suspended
  • Hematologic Neoplasms
  • donor lymphocyte infusion
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Nov 30, 2022

Hematopoietic Organs; Disorder Trial in Hong Kong (CD62L depleted donor lymphocyte infusion)

Recruiting
  • Hematopoietic Organs; Disorder
  • CD62L depleted donor lymphocyte infusion
  • Hong Kong, Hong Kong
    Hong Kong Children's Hospital
Sep 6, 2023

Chronic Myeloid Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Atlanta (G-CSF mobilized CD34+ selected

No longer available
  • Chronic Myeloid Leukemia
  • +2 more
  • G-CSF mobilized CD34+ selected cells for transplantation
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Feb 28, 2022

Hematologic Tumors Trial in France (Allogeneic (Allo) hematopoietic stem cell transplantation)

Completed
  • Hematologic Neoplasms
  • Allogeneic (Allo) hematopoietic stem cell transplantation
  • Amiens, France
  • +13 more
Jan 27, 2023

Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute Trial in Boston (radiation, drug, biological,

Recruiting
  • Stem Cell Transplant Complications
  • +4 more
  • Radiation
  • +7 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 19, 2023

Stem Cell Transplant Complications Trial in Suzhou (Eltrombopag 25 MG Oral Tablet, Thrombopoietin)

Not yet recruiting
  • Stem Cell Transplant Complications
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jul 17, 2022

Acute Leukemia, Acute Lymphocytic Leukemia, Acute Myelogenic Leukemia Trial (Haploidentical hematopoietic cell transplantation

Not yet recruiting
  • Acute Leukemia
  • +4 more
  • Haploidentical hematopoietic cell transplantation (haploHCT)
  • matched unrelated donor hematopoietic cell transplantation (MUD-HCT)
  • (no location specified)
Jul 13, 2022

Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia Trial in Gainesville (Orca-Q)

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Orca-Q
  • Gainesville, Florida
    University of Florida
Aug 26, 2022

Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (radiation, procedure, drug)

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Total-Body Irradiation
  • +5 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Sep 7, 2022

Living Donor Kidney Transplantation Trial in Palo Alto, Chicago (Infusion of Donor Hematopoetic Stem Cells and Recipient Tregs)

Recruiting
  • Living Donor Kidney Transplantation
  • Infusion of Donor Hematopoetic Stem Cells and Recipient Tregs
  • Palo Alto, California
  • +1 more
May 6, 2022

Donor COVID-19 Infection Status on the Recipient in Allo-HSCT

Recruiting
  • COVID-19
  • Hematopoietic Stem Cell Transplantation
    • Suzhou, Jiangsu, China
      First Affiliated Hospital of Soochow University
    Jan 10, 2023

    Renal Failure Trial in Chicago, Louisville (Enriched Hematopoietic Stem Cell Infusion)

    Active, not recruiting
    • Renal Failure
    • Enriched Hematopoietic Stem Cell Infusion
    • Chicago, Illinois
    • +1 more
    Jul 15, 2022

    Mucopolysaccharidosis Disorders, Hurler Syndrome, Hunter Syndrome Trial in Minneapolis (Stem Cell Transplantation, IMD

    Recruiting
    • Mucopolysaccharidosis Disorders
    • +28 more
    • Stem Cell Transplantation
    • +7 more
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Nov 1, 2022

    Kidney Failure Trial in Chicago, Durham (Enriched Hematopoietic Stem Cell Infusion)

    Active, not recruiting
    • Kidney Failure
    • Enriched Hematopoietic Stem Cell Infusion
    • Chicago, Illinois
    • +1 more
    Jul 15, 2022

    DOCK8 Deficiency Trial run by the National Cancer Institute (NCI) (Reduced-intensity hematopoietic stem cell,

    Recruiting
    • DOCK8 Deficiency
    • Reduced-intensity hematopoietic stem cell
    • +6 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 27, 2023

    Relapsed/Refractory Acute Myeloid Leukemia (AML) Trial in Dresden, Heidelberg (Donor-derived CD34+ HSC with CRISPR/Cas9-mediated

    Not yet recruiting
    • Relapsed/Refractory Acute Myeloid Leukemia (AML)
    • Donor-derived CD34+ HSC with CRISPR/Cas9-mediated CD33 deletion
    • Gemtuzumab Ozogamicin
    • Dresden, Germany
    • +1 more
    Dec 20, 2022

    Relapsed Adult ALL, Relapsed Adult AML Trial in Changchun (Plerixafor)

    Active, not recruiting
    • Relapsed Adult ALL
    • Relapsed Adult AML
    • Changchun, Jilin, China
      First Hospital of Jilin University
    Nov 19, 2023